CDC42EP2
Cdc42 effector protein 2
Also known as: BORG1, BORG1_HUMAN, CEP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14613
- Gene
- CDC42EP2
- Ensembl
- ENSG00000149798
- Chromosome
- 11
- Canonical length
- 210 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Microtubules,Cytosol
OverviewNCBI Gene
CDC42, a small Rho GTPase, regulates the formation of F-actin-containing structures through its interaction with the downstream effector proteins. The protein encoded by this gene is a member of the Borg family of CDC42 effector proteins. Borg family proteins contain a CRIB (Cdc42/Rac interactive-binding) domain. They bind to, and negatively regulate the function of CDC42. Coexpression of this protein with CDC42 suggested a role of this protein in actin filament assembly and cell shape control. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
210 residues, UniProt reviewed canonical sequence.
>O14613|CDC42EP2
1 MSTKVPIYLK RGSRKGKKEK LRDLLSSDMI SPPLGDFRHT IHIGSGGGSD MFGDISFLQG
61 KFHLLPGTMV EGPEEDGTFD LPFQFTRTAT VCGRELPDGP SPLLKNAISL PVIGGPQALT
121 LPTAQAPPKP PRLHLETPQP SPQEGGSVDI WRIPETGSPN SGLTPESGAE EPFLSNASSL
181 LSLHVDLGPS ILDDVLQIMD QDLDSMQIPTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDC42EP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 40 nTPM
- spinal cord: 24 nTPM
- heart muscle: 22 nTPM
- breast: 22 nTPM
- lung: 18 nTPM
- urinary bladder: 18 nTPM
Single-cell type
- podocytes: 18 nCPM
- oligodendrocytes: 17 nCPM
- renal collecting duct principal cells: 6.8 nCPM
- papillary tip epithelial cells: 5.7 nCPM
- renal connecting tubule cells: 2.2 nCPM
- lymphatic endothelial cells: 1.7 nCPM
Immune cell
- neutrophil: 173 nTPM
- intermediate monocyte: 120 nTPM
- non-classical monocyte: 91 nTPM
- classical monocyte: 51 nTPM
- total PBMC: 18 nTPM
- myeloid DC: 11 nTPM
Brain region
- white matter: 89 nTPM
- medulla oblongata: 51 nTPM
- basal ganglia: 51 nTPM
- midbrain: 48 nTPM
- cerebral cortex: 48 nTPM
- pons: 45 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.77
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.52
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- actin filament organization
- cellular response to type II interferon
- positive regulation of actin filament polymerization
- positive regulation of protein-containing complex assembly
- positive regulation of pseudopodium assembly
- regulation of cell shape
- Rho protein signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDC42EP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDC42EP2 as an antibody target. Whether an autoantibody or antibody against CDC42EP2 could matter depends on whether native CDC42EP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDC42EP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDC42EP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...